Intraday News Mover:: Pacific Biosciences of California, Inc., (NASDAQ: PACB)

 

On Monday, November 16, 2020, the Company, Pacific Biosciences of California, Inc., PACB stock construct a change of -6.81 percent (Loss) in a total of its share price and having its trading value $15.6, which belongs to Healthcare sector and Diagnostics & Research industry. The company?s Market capitalization was $2.81B with the total Outstanding Shares of 166.86M.

 


P/S, P/E, P/B & P/C values of (NASDAQ: PACB):

 

Pacific Biosciences of California, Inc. institutional ownership is standing at 87.8 percent, while insider ownership is 2 percent. As of now, PACB has a P/S, P/E and, P/B values of 35.24, 0, and 20 respectively. Its P/Cash is valued at 13.47.

 

The stock SMA50 is now at 33.36 percent. In looking, the SMA 200 we see that the stock has seen a 165.87 percent. The Company?s net profit margin for the 12 months at -57.3 percent. Comparatively, the gazes have a Gross margin of 42.8 percent.


Profitability ratios:

 

Looking into the profitability ratios of PACB stock, an investor will find its ROE, ROA, ROI standing at -63.8 percent, -20.4 percent and, -116.6 percent, respectively.


Beta Factor:

 

A beta factor is used to measure the volatility of the stock. The stock remaining at 9.11 percent volatile for the week and 8.2 percent for the month.


Gross / Operating Margins of PACB:

 

It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 42.8 percent & Operating Margin seen at -58.1 percent.


Target Price:

 

Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Pacific Biosciences of California, Inc. recorded it at $14.


Historical Performance In The News:

 

Taking a look at the performance of Pacific Biosciences of California, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 5.05 percent, resulting in a performance for the month at 8.56 percent.

Therefore, the stated figure displays a quarterly performance of 150 percent, bringing six-month performance to 334.54 percent and year to date performance of 203.5 percent. As of now, Pacific Biosciences of California, Inc. has a P/S, P/E and, P/B values of 35.24, 0, and 20 respectively. Its P/Cash is valued at 13.47.


Earnings per Share Details of Pacific Biosciences of California, Inc.:

 

The EPS of PACB is strolling at -0.28, measuring its EPS growth this year at 27.3 percent. As a result, the company has an EPS growth of -883.3 percent for the approaching year.